$1,70 tamiflu and relenza are proving to be in effective in treating h5n1 as the virus is documenting resistance.
bta, page-2
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online